BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28271698)

  • 1. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects.
    Ruderman R; Pavone ME
    Minerva Ginecol; 2017 Jun; 69(3):286-294. PubMed ID: 28271698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer in endometriosis: clinical and molecular aspects.
    Lyttle B; Bernardi L; Pavone ME
    Minerva Ginecol; 2014 Apr; 66(2):155-64. PubMed ID: 24848074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.
    Gadducci A; Lanfredini N; Tana R
    Gynecol Endocrinol; 2014 Sep; 30(9):612-7. PubMed ID: 24905724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
    Munksgaard PS; Blaakaer J
    Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
    Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
    Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.
    Steinbuch SC; Lüß AM; Eltrop S; Götte M; Kiesel L
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities.
    Shigetomi H; Tsunemi T; Haruta S; Kajihara H; Yoshizawa Y; Tanase Y; Furukawa N; Yoshida S; Sado T; Kobayashi H
    Cancer Invest; 2012 Jul; 30(6):473-80. PubMed ID: 22530740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
    Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; Abrão MS
    J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
    Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
    Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.
    Viganó P; Somigliana E; Chiodo I; Abbiati A; Vercellini P
    Hum Reprod Update; 2006; 12(1):77-89. PubMed ID: 16172112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Implications for Patients with Endometriosis.
    Wilbur MA; Shih IM; Segars JH; Fader AN
    Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis.
    Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M
    Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endometriosis and endometriosis-related ovarian neoplasms].
    Totev T; Tomov S; Gorchev G
    Akush Ginekol (Sofiia); 2013; 52(6):38-42. PubMed ID: 24501879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis.
    Stewart CJ; Walsh MD; Budgeon CA; Crook ML; Buchanan DB
    Pathology; 2013 Oct; 45(6):559-66. PubMed ID: 24018808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of endometriosis and ovarian malignancy: a review.
    Nezhat F; Datta MS; Hanson V; Pejovic T; Nezhat C; Nezhat C
    Fertil Steril; 2008 Nov; 90(5):1559-70. PubMed ID: 18993168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.
    Bulun SE; Wan Y; Matei D
    Endocrinology; 2019 Mar; 160(3):626-638. PubMed ID: 30657901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endometriosis in cancer and tumor development.
    Swiersz LM
    Ann N Y Acad Sci; 2002 Mar; 955():281-92; discussion 293-5, 396-406. PubMed ID: 11949955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
    Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
    Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.